Your browser doesn't support javascript.
loading
Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.
Labaeka, A A; Falade, A G; Addo-Yobo, E O D; Mortimer, K; Zurba, L; Lesosky, M; Ellwood, P; Asher, M I.
Afiliação
  • Labaeka AA; Department of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Department of Paediatrics, University College Hospital, Ibadan, Nigeria.
  • Falade AG; Department of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Department of Paediatrics, University College Hospital, Ibadan, Nigeria.
  • Addo-Yobo EOD; Kwame Nkrumah University of Science and Technology, Kumasi, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
  • Mortimer K; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK, University of KwaZulu Natal, Durban.
  • Zurba L; Spirometry Training Services Africa, Durban.
  • Lesosky M; Division of Epidemiology & Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
  • Ellwood P; Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland, New Zealand.
  • Asher MI; Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland, New Zealand.
Int J Tuberc Lung Dis ; 27(12): 925-930, 2023 Dec 01.
Article em En | MEDLINE | ID: mdl-38042979
ABSTRACT

BACKGROUND:

Phases I and III of the International Study of Asthma and Allergies in Childhood (ISAAC) documented increased asthma symptoms among Nigerian 13-14-year old adolescents. We investigated the trend further using the Global Asthma Network (GAN) surveillance.

METHODS:

Using ISAAC methodology, GAN Phase I data on symptoms and risk factors for asthma and asthma management were obtained from February to July 2018.

RESULTS:

There were 2,897 adolescents from 23 secondary schools. For current wheeze, there was an absolute prevalence fall per decade of -1.4 with -1 standard error (SE) in 16 years from 2002 (ISAAC Phase III) to 2018 (GAN Phase I). This pattern was evident for prevalence of reported asthma ever, severe asthma symptoms and night cough with ≥1 SE. During the 23-year interval between ISAAC Phase I and GAN Phase I, there was a fall (≥1 SE) in the absolute prevalence of reported asthma ever, severe asthma symptoms and night cough, except for severe asthma symptoms (-0.2 SE). Respectively 36% and 43% of symptomatic adolescents purchased and used salbutamol and prednisolone.

CONCLUSION:

The prevalence and severity of asthma symptoms remain high among adolescents in Ibadan. This could be mitigated by improved access to affordable and effective asthma treatments.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Tosse Limite: Adolescent / Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Tosse Limite: Adolescent / Humans País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article